Fatal Propafenone Overdoses: Case Reports and A Review of the Literature

Journal of Analytical Toxicology

Volumn 27, Issue 8, 2003, Pages 595-599

  Clarot, Franck ^a   Goullé, Jean Pierre ^b   Horst, Marlène ^a   Vaz, Emmanuelle ^a   Lacroix, Christian ^b   Proust, Bernard ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b Group Hospitalier Jacques Monod   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYPROPAFENONE; NORPROPAFENONE; PROPAFENONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFACT; AUTOPSY; CASE REPORT; DIODE; DIODE ARRAY DETECTOR; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG OVERDOSE; DRUG SELF ADMINISTRATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY;

EID: 0344629150     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/27.8.595     Document Type: Article

References (29)

1. K. Fonck, C. Haenebalcke, A. Hemeryck, F. Belpaire, L. Jordaens, P. Calle, and W. Buylaert. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. Clin. Toxicol. 36: 247-251 (1998)
2. H. Müller-Peltzer G. Greger, G. Neugebauer, and M. Hollmann. Beta-blocking and electrophysiological effects of propafenenone in volunteers. Eur. J. Clin. Pharmacol. 25: 831-833 (1983).
3. M.J. Ellenhorn and D.G. Barceloux. Antiarrhythmic drugs. In Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning, William & Wilkins, Baltimore, MD, 1997, pp 169-187.
4. J.T. Lee, D.J. Silverstein, C. Funck-Brentano, M.D. Lineberry, A.J. Wood, D.M. Roden, and R.L. Woosley. The role of genetically determined polymorphic drug metabolism in the beta-blockade producted by propafenone. N. Engl. J. Med. 322: 1764-1768 (1990).
5. F. Ledda, L. Mantelli, S. Manzini, S. Amerini, and A. Mugelli. Electrophysiological and antiarrhythmic properties of propafenone in isolated cardiac preparations. J. Cardiovasc. Pharmacol. 3: 1162-1173 (1981).
6. J.T. Hii, H.J. Duff, and E.D. Burgess. Clinical pharmacokinetics of propafenone. Clin. Pharmacokinet. 21: 1-10 (1991).
7. S. Vozeh, W. Haefeli, W.R. Ha, J. Vlcek, and F. Follath. Non linear kinetics of propafenone metabolites in healthy man. Eur. J. Clin. Pharmacol. 38: 509-513 (1990).
8. C. Funck-Brentano, H.K. Kroemer, and J.T. Lee. Drug therapy: propafenone. N. Engl. J. Med. 322: 518-525 (1990).
9. C. Köppel, U. Oberdisse, and G. Heinemeyer. Clinical course and outcome in class Ic antiarrhythmic overdose. J. Toxicol. Clin. Toxicol. 28: 433-444 (1990).
10. L.A. Siddoway, K.A. Thompson, C.B. McAllister, T. Wang, G.R. Wilkinson, D.M. Rosen, and R.L. Woosley. Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequence. Circulation 75: 787-791 (1987).
11. F. Chouty. Intravenous sodium lactate as a treatment of class I anti-arrhythmic agents overdose. Circulation 80: 411-430 (1989).
12. L.A. Siddoway, D.M. Roden, and R.L. Woosley. Clinical pharmacology of propafenone: metabolism and concentration-response relations. Am. J. Cardiol. 54: 9D-12D (1984).
13. K.A. Thompson, L.A. Siddoway, R.L. Woosley, et al. Patient dose-dependent electrophysiologic effects of the major metabolite of propafenone. Circulation 72(suppl III): 233 (1985).
14. S.J. Connolly, R.E. Kates, C.S. Lebsack, D.C. Harrisson, and R.A. Winkle. Clinical pharmacology of propafenone. Circulation 63: 589-596 (1983).
15. T. Budde, M. Beyer, G. Breihardt, J. Passlick, and B. Grabense. Therapy of severe propafenone poisoning: an attempt at elimination by hemoperfusion (abstract) Z. Kardiol. 75: 764-769 (1986).
16. W. Kerns, II, B. English, and M. Ford. Propafenone overdose. Ann. Emerg. Med. 24: 98-103 (1994).
17. T.P. Mc Hugh and D.G. Perina. Propafenone ingestion. Ann. Emerg. Med. 16: 437-440 (1987).
18. G. Ielasi, M. Panagia, L. Grasso, and G. Caminiti. Acute voluntary poisoning with propafenone. A clinical case. Minerva Anestesiol 59: 69-73 (1993).
19. G. Picciotto, V. Siragusa, M. Cellura, C. Ventimiglia, and L. Rotolo. Acute propafenone poisoning. Description of a case. Minerva Cardioangiol. 38: 555-558 (1990).
20. H. Lanquetot, Y. Furet, V. Kerourédan, O. Poitrineau, M. Hubiche, and E. Autret. Intoxication mortelle par association propafé none-amitriptyline: à propos d'un cas. Agressologie 29: 39-42 (1988).
21. P. Friocourt, C. Martin, and L. Lozac'h. Intoxication volontaire à la propafénone: a propos d'un cas. Ann. Cardiol. Angeiol. 37: 133-136 (1988).
22. O. Eray and J. Fowler. Severe propafenone poisoning responded to temporary internal pacemaker. Vet. Hum. Toxicol. 42: 289 (2000).
23. J.P. Camous, C. Ichai, P. Meyer, P. Gibelin, M. Baudouy, A. Varenne, and P. Morand. Traitement des intoxications aux nouveaux antiarythmiques (cibenzoline, flécaïnide, propafénone). Presse Méd. 16: 2076 (1987).
24. M.O. Rambourg-Schepen, F. Grossenbacher, M. Buffet, and D. Lamiable. Recurrent convusions and cardiac conduction disturbances after propafenone overdose. Vet. Hum. Toxicol. 41: 153-154 (1999).
25. M. Olm, M.J. Jimenez, and P. Munne. Efficacité de la methoxamine par voie veineuse lors des intoxications à la propafénone. Presse Méd. 18: 1124 (1989).
26. H. Maxeiner and E. Klug. Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries. Forensic Sci. Int. 89: 27-32 (1997).
27. A. Lanari, M. Brun, A. Dormi, M. Giunti, A. Mariani, V. Mariotti, G. Montanari, P. Volpe, and R. Amici. Propafenone and verapamil poisoning. Report of two clinical cases. Clin. Ther. 145: 457-461 (1994).
28. D.R.A. Uges. Therapeutic and toxic drug concentration. TIAFT Bull. Vol. 26, 1996.
29. R.C. Baselt and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute, Foster City, CA, 1995, p 654.